0,859  0,005  Caspase 9 stimulant
0,850  0,003  CTGF expression inhibitor
0,844  0,003  Antimutagenic
0,827  0,004  Amyloid beta aggregation inhibitor
0,813  0,004  Aldehyde oxidase inhibitor
0,810  0,004  UGT1A6 substrate
0,801  0,008  TNF expression inhibitor
0,768  0,003  Superoxide dismutase inhibitor
0,760  0,004  Free radical scavenger
0,749  0,005  UGT1A9 substrate
0,746  0,005  NOS2 expression inhibitor
0,739  0,004  Tubulin antagonist
0,739  0,015  Antineoplastic (breast cancer)
0,729  0,005  Antioxidant
0,740  0,024  Apoptosis agonist
0,712  0,005  Cardiovascular analeptic
0,701  0,014  Antineoplastic (colorectal cancer)
0,701  0,018  Antineoplastic (lung cancer)
0,691  0,007  12-Lipoxygenase inhibitor
0,682  0,004  Sulfotransferase substrate
0,688  0,014  Antineoplastic (colon cancer)
0,658  0,012  Chemoprotective
0,647  0,004  Skin whitener
0,656  0,017  Antileukemic
0,648  0,010  Antineoplastic (cervical cancer)
0,640  0,005  Antiseptic
0,658  0,025  Transcription factor NF kappa B inhibitor
0,640  0,011  CYP1A2 substrate
0,642  0,014  Prostate cancer treatment
0,635  0,008  Antineoplastic (non-small cell lung cancer)
0,621  0,003  SULT1A3 substrate
0,615  0,003  Pneumotoxic
0,614  0,004  Peroxidase inhibitor
0,620  0,011  Antineoplastic (melanoma)
0,610  0,003  UGT2B4 substrate
0,610  0,010  AR expression inhibitor
0,608  0,010  Caspase 3 stimulant
0,606  0,009  Lipoxygenase inhibitor
0,599  0,007  Antimitotic
0,599  0,011  NOS3 expression inhibitor
0,593  0,008  CYP1A2 inhibitor
0,602  0,021  CYP2C9 substrate
0,586  0,009  Antiamyloidogenic
0,599  0,024  GST A substrate
0,578  0,005  Monophenol monooxygenase inhibitor
0,576  0,004  Beta tubulin antagonist
0,573  0,004  Alpha tubulin antagonist
0,580  0,010  Ulceration
0,573  0,004  Amylase inhibitor
0,582  0,016  Sensitization
0,567  0,004  VCAM1 expression inhibitor
0,566  0,015  Chemopreventive
0,554  0,006  Genotoxic
0,559  0,015  Cardioprotectant
0,572  0,028  15-Lipoxygenase inhibitor
0,542  0,010  UDP-glucuronosyltransferase substrate
0,528  0,004  UGT2B15 substrate
0,542  0,019  Radioprotector
0,579  0,058  Alpha-glucosidase inhibitor
0,525  0,006  Melanin inhibitor
0,521  0,003  Cystathionine beta-synthase inhibitor
0,521  0,004  GST P1-1 substrate
0,528  0,015  Antineoplastic (glioma)
0,533  0,023  Antihypercholesterolemic
0,529  0,021  CYP2D6 substrate
0,521  0,016  FMO1 substrate
0,501  0,007  UGT1A3 substrate
0,504  0,014  Antineoplastic (glioblastoma multiforme)
0,513  0,025  Histamine release inhibitor
0,506  0,019  Proliferative diseases treatment
0,505  0,027  CYP2C19 substrate
0,504  0,026  Antineoplastic (ovarian cancer)
0,496  0,020  Antineoplastic (brain cancer)
0,503  0,027  5 Hydroxytryptamine release stimulant
0,486  0,011  UGT1A1 substrate
0,479  0,005  Breast cancer-resistant protein inhibitor
0,481  0,010  Pyruvate kinase inhibitor
0,488  0,018  Antiprotozoal (Leishmania)
0,489  0,019  Antineoplastic (multiple myeloma)
0,483  0,015  ICAM1 expression inhibitor
0,492  0,025  Aryl hydrocarbon receptor agonist
0,486  0,021  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,493  0,029  Vasodilator, peripheral
0,467  0,015  Antihypertriglyceridemic
0,460  0,009  Calcium channel activator
0,470  0,020  Vasodilator, coronary
0,454  0,006  NOS3 expression enhancer
0,478  0,030  CYP2C19 inhibitor
0,445  0,004  Carbonic anhydrase III inhibitor
0,456  0,015  Antineoplastic (osteosarcoma)
0,448  0,007  Lipid peroxidase inhibitor
0,453  0,019  Cardiodepressant
0,435  0,004  Carbonic anhydrase VI inhibitor
0,431  0,003  Keratolytic
0,460  0,034  Respiratory analeptic
0,446  0,021  Antipyretic
0,451  0,027  Apoptosis antagonist
0,438  0,017  Antineoplastic (renal cancer)
0,429  0,010  5 Hydroxytryptamine uptake stimulant
0,424  0,006  Tyrosine 3 hydroxylase inhibitor
0,420  0,004  M18 aspartyl aminopeptidase inhibitor
0,461  0,047  5 Hydroxytryptamine release inhibitor
0,452  0,040  Cholesterol antagonist
0,419  0,007  Protein kinase stimulant
0,433  0,022  Nitric oxide antagonist
0,431  0,022  Tumour necrosis factor alpha release inhibitor
0,456  0,047  Antipruritic, allergic
0,432  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,408  0,005  5-Lipoxygenase inhibitor
0,412  0,011  Antihypotensive
0,403  0,004  Carbonic anhydrase XV inhibitor
0,421  0,022  Radiosensitizer
0,398  0,003  SULT1A1 substrate
0,440  0,045  GABA C receptor rho-3 antagonist
0,425  0,033  Antineoplastic (pancreatic cancer)
0,407  0,016  Cyclic AMP phosphodiesterase inhibitor
0,394  0,006  Amyloid beta precursor protein antagonist
0,400  0,016  P-glycoprotein inhibitor
0,395  0,013  GST M1-1 substrate
0,406  0,023  Antihypoxic
0,398  0,015  UGT1A4 substrate
0,478  0,097  Antiinflammatory
0,388  0,010  DNA methyltransferase I inhibitor
0,380  0,004  Carbonic anhydrase XIII inhibitor
0,379  0,004  LDLR expression enhancer
0,401  0,028  DNA damaging
0,420  0,048  Angiogenesis inhibitor
0,394  0,024  Antineoplastic (liver cancer)
0,413  0,052  CYP2C9 inhibitor
0,367  0,007  Chelator
0,382  0,023  Antineoplastic (small cell lung cancer)
0,361  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,386  0,030  Hypoglycemic
0,441  0,084  Antineoplastic (solid tumors)
0,401  0,049  Bone diseases treatment
0,358  0,008  Glutathione S-transferase substrate
0,354  0,005  Beta glucuronidase inhibitor
0,409  0,060  CYP3A4 substrate
0,372  0,026  Transcription factor STAT3 inhibitor
0,361  0,015  DNA methylase inhibitor
0,371  0,028  FMO3 substrate
0,348  0,005  Dementia treatment
0,345  0,004  Macrophage migration inhibitory factor inhibitor
0,353  0,012  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,361  0,022  Antineoplastic (sarcoma)
0,342  0,005  Vascular dementia treatment
0,341  0,005  Nitric-oxide synthase stimulant
0,339  0,006  Succinate dehydrogenase inhibitor
0,349  0,015  MAO inhibitor
0,362  0,030  Transcription factor STAT inhibitor
0,344  0,015  Interferon gamma antagonist
0,339  0,010  Antihelmintic (Nematodes)
0,330  0,004  Toll-Like receptor 2 antagonist
0,341  0,016  Antineoplastic (squamous cell carcinoma)
0,335  0,011  CYP2B6 inhibitor
0,331  0,008  Antifungal enhancer
0,367  0,045  Antiosteoporotic
0,328  0,006  Xanthine oxidase inhibitor
0,365  0,047  Analeptic
0,366  0,048  Spasmolytic
0,328  0,012  Neurotrophic factor enhancer
0,327  0,011  Cyclooxygenase 1 inhibitor
0,320  0,005  Histidine decarboxylase inhibitor
0,349  0,036  Mutagenic
0,326  0,014  Tumour necrosis factor antagonist
0,339  0,029  Antineoplastic enhancer
0,340  0,032  Interleukin agonist
0,336  0,033  Sigma receptor agonist
0,316  0,013  MAO A inhibitor
0,312  0,010  Cholesterol synthesis inhibitor
0,304  0,005  Choleretic
0,302  0,004  NAD(P)H dehydrogenase (quinone) inhibitor
0,302  0,005  UGT2B10 substrate
0,301  0,005  HIV-1 integrase (Strand Transfer) inhibitor
0,298  0,005  VEGF expression inhibitor
0,322  0,031  Abortion inducer
0,295  0,006  Estrogen antagonist
0,321  0,034  Antineoplastic (bladder cancer)
0,304  0,017  Antineoplastic (gastric cancer)
0,329  0,043  Antineoplastic (lymphoma)
0,332  0,046  Cytotoxic
0,388  0,102  Alzheimer's disease treatment
0,325  0,040  Angiogenesis stimulant
0,328  0,046  Antineoplastic (endocrine cancer)
0,365  0,084  Antiprotozoal
0,308  0,027  Hepatoprotectant
0,318  0,038  Antineoplastic (lymphocytic leukemia)
0,305  0,025  UGT2B7 substrate
0,370  0,091  Antibacterial
0,323  0,046  Insulysin inhibitor
0,285  0,009  UGT2B1 substrate
0,318  0,042  Vasodilator
0,321  0,047  Cytostatic
0,284  0,015  NADPH oxidase inhibitor
0,283  0,014  MAO B inhibitor
0,283  0,015  Antineoplastic (bone cancer)
0,370  0,103  Calcium channel L-type activator
0,295  0,029  Non-steroidal antiinflammatory agent
0,307  0,041  Antiulcerative
0,269  0,004  Histone deacetylase stimulant
0,269  0,004  Histone deacetylase SIRT1 stimulant
0,268  0,005  Vanilloid 1 agonist
0,347  0,084  Prostaglandin dehydrogenase inhibitor
0,272  0,011  Interleukin 4 antagonist
0,296  0,035  Platelet adhesion inhibitor
0,276  0,015  Alkaline phosphatase inhibitor
0,278  0,018  Heat shock protein 90 alpha antagonist
0,264  0,006  Estrogen receptor beta antagonist
0,382  0,126  DNA polymerase beta inhibitor
0,258  0,004  SULT1E1 substrate
0,299  0,045  Carcinogenic
0,279  0,026  Antipruritic, non-allergic
0,326  0,074  Antithrombotic
0,265  0,015  Carcinogenic, group 1
0,267  0,020  Antidote
0,280  0,036  RNA-directed DNA polymerase inhibitor
0,277  0,033  Dual specificity phosphatase 3 inhibitor
0,266  0,022  Topoisomerase II inhibitor
0,260  0,018  Heat shock protein 90 antagonist
0,303  0,062  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,256  0,016  DNA polymerase I inhibitor
0,251  0,013  Expectorant
0,271  0,033  Dual specificity phosphatase inhibitor
0,285  0,048  Antiparasitic
0,236  0,002  UGT2B11 substrate
0,290  0,059  Flavin-containing monooxygenase substrate
0,270  0,039  Antihelmintic
0,362  0,133  DNA directed DNA polymerase inhibitor
0,303  0,076  Sodium/bile acid cotransporter inhibitor
0,233  0,006  Antineoplastic (uterine cancer)
0,237  0,010  Cyclooxygenase 3 inhibitor
0,304  0,077  Streptokinase A inhibitor
0,338  0,113  Antiparkinsonian
0,254  0,029  Antineoplastic (carcinoma)
0,268  0,043  Anesthetic general
0,246  0,021  UGT2B9 substrate
0,235  0,013  Interleukin 1b antagonist
0,272  0,052  5 Hydroxytryptamine 1E antagonist
0,225  0,004  DOPA decarboxylase inhibitor
0,300  0,081  Antifungal
0,230  0,012  Topoisomerase II alpha inhibitor
0,245  0,028  Histone acetyltransferase inhibitor
0,250  0,034  Insulin sensitizer
0,219  0,006  Vanilloid agonist
0,228  0,016  Antihemorrhagic
0,220  0,008  Creatine kinase inhibitor
0,243  0,033  Protein-tyrosine phosphatase inhibitor
0,257  0,048  ErbB-1 antagonist
0,213  0,005  Heat shock protein 70 antagonist
0,211  0,003  SULT1A2 substrate
0,231  0,023  Interleukin 1 antagonist
0,215  0,007  Estrogen agonist
0,275  0,068  Antiprotozoal (Trypanosoma)
0,244  0,038  Mcl-1 antagonist
0,228  0,023  Antiprotozoal (Coccidial)
0,215  0,009  Gastritis treatment
0,235  0,030  Carcinogenic, group 3
0,266  0,061  Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor
0,234  0,030  Cyclooxygenase inhibitor
0,220  0,016  Microtubule formation inhibitor
0,214  0,010  Mucolytic
0,233  0,029  Phospholipase C inhibitor
0,225  0,022  ATPase inhibitor
0,210  0,007  Thioredoxin inhibitor
0,260  0,058  Interleukin antagonist
0,228  0,026  Acetylcholinesterase inhibitor
0,210  0,010  Adenylate cyclase stimulant
0,211  0,011  Antihelmintic (Trematoda)
0,220  0,020  Antirickettsial
0,227  0,028  Aldehyde oxidase substrate
0,218  0,021  GABA C receptor rho-2 antagonist
0,223  0,026  Neurotensin receptor agonist
0,231  0,037  Acaricide
0,212  0,019  Carcinogenic, group 2B
0,210  0,017  CF transmembrane conductance regulator agonist
0,215  0,023  Mannose-6-phosphate isomerase inhibitor
0,198  0,007  Carbonic anhydrase V inhibitor
0,199  0,011  TRPA1 agonist
0,238  0,050  Antiviral (West Nile virus)
0,208  0,019  Farnesoid X receptor antagonist
0,192  0,005  Myeloperoxidase inhibitor
0,204  0,018  Bronchodilator
0,215  0,029  Uterine stimulant
0,326  0,141  Transcription factor inhibitor
0,189  0,005  Antifungal (Pneumocystis)
0,257  0,072  Vascular (periferal) disease treatment
0,232  0,048  I kappa B kinase epsilon inhibitor
0,212  0,029  Hexokinase inhibitor
0,188  0,008  Phenylalanine 4-hydroxylase inhibitor
0,254  0,075  Teratogen
0,216  0,040  Cytidine deaminase inhibitor
0,204  0,028  Protein-tyrosine phosphatase 1B inhibitor
0,180  0,009  Glutamate decarboxylase inhibitor
0,245  0,074  Dyrk kinase inhibitor
0,175  0,005  Antifungal (Aspergillus)
0,204  0,033  Phobic disorders treatment
0,176  0,007  Carbonic anhydrase VA inhibitor
0,227  0,058  Antiviral (Influenza)
0,279  0,113  Antiprotozoal (Plasmodium)
0,193  0,028  Topoisomerase I inhibitor
0,211  0,047  Eye irritation, high
0,170  0,007  Carbonic anhydrase VB inhibitor
0,198  0,035  Arachidonic acid antagonist
0,179  0,017  HIV-1 integrase (Overall Integration) inhibitor
0,179  0,018  Aldehyde dehydrogenase substrate
0,182  0,022  Coagulant
0,172  0,012  Toll-Like receptor 4 antagonist
0,228  0,068  Peptidyltransferase inhibitor
0,166  0,006  Estrogen receptor beta agonist
0,167  0,010  Estrogen receptor alpha antagonist
0,176  0,019  Mediator release inhibitor
0,170  0,015  Prolactin inhibitor
0,232  0,078  Embryotoxic
0,189  0,037  Skin irritative effect
0,255  0,106  Hepatic disorders treatment
0,154  0,005  Carbonic anhydrase XIV inhibitor
0,154  0,006  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,186  0,038  Alpha-N-acetylglucosaminidase inhibitor
0,152  0,005  Granulocyte macrophage colony stimulating factor agonist
0,174  0,027  Beta amyloid protein antagonist
0,183  0,037  Toll-Like receptor antagonist
0,153  0,008  HIV-1 integrase inhibitor
0,189  0,044  CNS active muscle relaxant
0,164  0,020  Multidrug resistance-associated protein 1 inhibitor
0,165  0,020  Antiviral (Influenza B)
0,199  0,057  Muscle relaxant
0,185  0,043  Antidiarrheal
0,165  0,023  Papain-like protease (SARS coronavirus) inhibitor
0,186  0,045  Skeletal muscle relaxant
0,175  0,034  Movement disorders treatment
0,154  0,014  Paget's disease treatment
0,157  0,017  Electron transport complex I inhibitor
0,215  0,075  Antiparkinsonian, rigidity relieving
0,147  0,007  Xanthine dehydrogenase inhibitor
0,175  0,037  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,143  0,005  Estrogen receptor alpha agonist
0,144  0,006  Anticholelithogenic
0,148  0,011  Ornithine decarboxylase inhibitor
0,176  0,039  Cyclooxygenase 2 inhibitor
0,156  0,020  Urease inhibitor
0,168  0,034  Antibacterial (Helicobacter pylori)
0,138  0,005  Endocannabinoid uptake inhibitor
0,159  0,026  Photosensitizer
0,135  0,005  Estrogen-related receptor beta agonist
0,134  0,005  GABA B receptor agonist
0,168  0,038  Antihyperlipoproteinemic
0,133  0,004  Glucose-6-phosphate translocase inhibitor
0,136  0,007  Estradiol 17 beta-dehydrogenase inhibitor
0,157  0,028  Ca2+-transporting ATPase inhibitor
0,167  0,038  Aldehyde dehydrogenase inhibitor
0,231  0,103  Antituberculosic
0,154  0,026  AMP-activated protein kinase stimulant
0,136  0,008  D-Ala-D-Ala ligase inhibitor
0,205  0,077  Psychostimulant
0,153  0,027  Antihelmintic (Fasciola)
0,158  0,032  Sphingosine 1-phosphate receptor 2 antagonist
0,130  0,004  Catechol O-methyltransferase inhibitor
0,148  0,025  Sphingomyelinase inhibitor
0,135  0,012  Aldose reductase inhibitor
0,127  0,007  Aryl hydrocarbon receptor antagonist
0,129  0,009  Elastase 1 inhibitor
0,165  0,047  Neurotrophic factor
0,160  0,042  Alkylator
0,136  0,018  Interleukin 12 antagonist
0,159  0,042  Antiprotozoal (Trichomonas)
0,199  0,082  Age-related macular degeneration treatment
0,130  0,014  Thioredoxin reductase inhibitor
0,120  0,004  Transcription factor RelA inhibitor
0,148  0,033  DNA repair enzyme inhibitor
0,212  0,099  Myocardial infarction treatment
0,174  0,060  Catenin beta inhibitor
0,126  0,013  Alcohol oxidase inhibitor
0,148  0,035  Contraceptive female
0,213  0,102  Calpain inhibitor
0,211  0,100  Neuropeptide Y2 antagonist
0,214  0,103  DNA synthesis inhibitor
0,124  0,014  Leukotriene antagonist
0,190  0,080  Antiviral (Ebola)
0,169  0,060  Phospholipase A2 inhibitor
0,124  0,014  GABA aminotransferase inhibitor
0,130  0,022  Antidote, mercury
0,117  0,008  Carbonic anhydrase VII inhibitor
0,135  0,027  Phosphodiesterase IV inhibitor
0,157  0,049  Antifungal (Cryptococcus)
0,227  0,120  Antiischemic
0,142  0,036  Protein kinase C gamma inhibitor
0,161  0,055  Cell wall synthesis inhibitor
0,149  0,044  Antiprotozoal (Amoeba)
0,155  0,050  Antieczematic
0,122  0,018  Bile acid receptor antagonist
0,133  0,029  Anabolic
0,235  0,131  CYP3A4 inhibitor
0,115  0,013  Purinergic P2X1 antagonist
0,121  0,019  CDC25A inhibitor
0,131  0,029  Carcinogenic, group 2A
0,139  0,038  Butyrylcholinesterase inhibitor
0,140  0,041  Alcohol dehydrogenase substrate
0,105  0,006  Heme oxygenase stimulant
0,154  0,056  Sphingosine 1-phosphate receptor 5 antagonist
0,102  0,004  Dopamine D5 agonist
0,135  0,038  Transcription factor STAT6 inhibitor
0,118  0,022  Purinergic P2X2 antagonist
0,114  0,019  Aromatase inhibitor
0,125  0,029  Antispirochetal
0,224  0,130  Antimycobacterial
0,119  0,025  Inducible nitric-oxide synthase inhibitor
0,130  0,036  Chronic obstructive bronchitis treatment
0,115  0,023  ATPase (Vacuolar H+) inhibitor
0,123  0,031  Protein kinase C zeta inhibitor
0,117  0,026  Antifungal (Candida)
0,097  0,006  Squalene epoxidase inhibitor
0,112  0,021  Dopamine D1 antagonist
0,130  0,039  Myasthenia Gravis treatment
0,126  0,035  GABA C receptor rho-1 antagonist
0,136  0,047  Sphingosine 1-phosphate receptor 4 antagonist
0,227  0,139  Thyroid hormone antagonist
0,127  0,038  Acetylcholine release stimulant
0,126  0,038  Antiprotozoal (Toxoplasma)
0,102  0,014  Potassium channel (ATP-sensitive) blocker
0,117  0,030  NADH dehydrogenase inhibitor
0,116  0,029  Phosphodiesterase 6D inhibitor
0,098  0,013  Antiviral (Parainfluenza)
0,090  0,007  Vanilloid 2 antagonist
0,113  0,031  Phosphodiesterase 4D inhibitor
0,093  0,012  Leukotriene B4 antagonist
0,162  0,081  Liver fibrosis treatment
0,144  0,064  Bone formation stimulant
0,089  0,009  Postcoital contraceptive
0,223  0,143  Antiallergic
0,114  0,035  Actinic keratosis treatment
0,134  0,055  Antitussive
0,085  0,006  Ryanodine receptor antagonist
0,092  0,013  SULT2A1 substrate
0,237  0,159  Immunosuppressant
0,116  0,038  Alcohol dehydrogenase inhibitor
0,096  0,018  Beta adrenoreceptor antagonist
0,085  0,008  Estrogen-related receptor alpha antagonist
0,081  0,003  CYP24 inhibitor
0,120  0,043  UDP-glucose 4-epimerase inhibitor
0,227  0,150  Thioredoxin glutathione reductase inhibitor
0,125  0,048  GABA C receptor antagonist
0,217  0,140  Thyroid hormone beta antagonist
0,082  0,006  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,101  0,026  Leukotriene synthesis inhibitor
0,117  0,043  GST T1-1 substrate
0,117  0,043  Potassium channel (Ca-activated) activator
0,091  0,018  Beta 3 adrenoreceptor antagonist
0,132  0,059  Anesthetic local
0,096  0,023  Glycine receptor agonist
0,141  0,069  Toll-Like receptor 9 antagonist
0,088  0,016  Heat shock protein 90 beta antagonist
0,106  0,033  Tocolytic
0,154  0,083  Interleukin 6 antagonist
0,120  0,049  GABA C receptor agonist
0,088  0,017  Transcription factor AP-1 inhibitor
0,091  0,020  Maillard reaction inhibitor
0,104  0,034  Glutathione S-transferase inhibitor
0,086  0,016  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,116  0,047  Gastric antisecretory
0,147  0,079  Cholinergic
0,081  0,013  Topoisomerase II beta inhibitor
0,087  0,020  Postmenopausal disorders treatment
0,104  0,037  Catalase inhibitor
0,192  0,125  Immunostimulant
0,146  0,081  Antiviral (Herpes)
0,129  0,065  Cathepsin H inhibitor
0,106  0,042  Antiviral (Rhinovirus)
0,118  0,055  Falcipain 3 inhibitor
0,085  0,022  Uterine relaxant
0,085  0,022  Antidote, heavy metal
0,072  0,010  Factor III inhibitor
0,089  0,027  MAP kinase kinase 7 inhibitor
0,137  0,077  Hair growth stimulant
0,092  0,032  Narcotic antagonist
0,078  0,019  Beta 1 adrenoreceptor antagonist
0,128  0,070  Retinoprotector
0,145  0,087  Neuropathy treatment
0,082  0,024  Neuraminidase (influenza) inhibitor
0,153  0,095  Myocardial ischemia treatment
0,082  0,025  Glutamate (mGluR7) antagonist
0,082  0,025  5 Hydroxytryptamine 2A agonist
0,061  0,005  Vanilloid 3 antagonist
0,072  0,015  Dihydroorotate oxidase inhibitor
0,135  0,078  Antiparkinsonian, tremor relieving
0,139  0,083  Antiviral (Influenza A)
0,062  0,006  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,133  0,077  Cytokine production inhibitor
0,075  0,020  Calcium channel P-type blocker
0,104  0,049  Uric acid excretion stimulant
0,102  0,047  Calcium antagonist
0,081  0,027  CDC25B inhibitor
0,093  0,038  Na+ K+ transporting ATPase inhibitor
0,069  0,015  Pregnane X receptor antagonist
0,069  0,015  Leukotriene C antagonist
0,078  0,024  Antimycoplasmal
0,104  0,050  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,098  0,045  Arylamine N-Acetyltransferase substrate
0,065  0,011  Dopamine beta hydroxylase inhibitor
0,073  0,020  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,067  0,014  Adenylate cyclase 1 inhibitor
0,128  0,075  Anesthetic
0,085  0,032  Antitreponemal
0,068  0,016  Glutamate (mGluR group III) agonist
0,104  0,052  Glutamate (mGluR7) agonist
0,120  0,068  Adenylate cyclase inhibitor
0,072  0,021  Sphingosine kinase 2 inhibitor
0,108  0,059  Alpha 2c adrenoreceptor antagonist
0,147  0,097  Antianginal
0,057  0,007  Nucleoside transporters inhibitor
0,058  0,009  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,067  0,018  Beta 2 adrenoreceptor antagonist
0,076  0,028  TRPA1 antagonist
0,065  0,018  Anesthetic inhalation
0,116  0,069  Proteasome inhibitor
0,138  0,091  Raynaud's phenomenon treatment
0,135  0,088  Hemostatic
0,074  0,027  Hypercalcemia treatment
0,078  0,032  Hyperparathyroidism treatment
0,162  0,116  Proto-oncogene tyrosine-protein kinase Fyn inhibitor
0,114  0,069  Caspase 3 inhibitor
0,117  0,072  Growth stimulant
0,087  0,043  Porphobilinogen synthase inhibitor
0,051  0,007  NMDA 2D receptor antagonist
0,110  0,066  Polo-like kinase-4 inhibitor
0,095  0,051  Glutamate release inhibitor
0,054  0,010  Vesicle monoamine transporter inhibitor
0,094  0,051  Androgen antagonist
0,128  0,086  Death-associated protein kinase 1 inhibitor
0,105  0,063  Gout treatment
0,067  0,026  Beta 2 adrenoreceptor agonist
0,147  0,106  3C-like protease (Human coronavirus) inhibitor
0,072  0,032  Neuraminidase inhibitor
0,180  0,140  Lipoprotein disorders treatment
0,056  0,015  Liver X receptor alpha agonist
0,048  0,007  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,134  0,094  Restenosis treatment
0,080  0,040  Phosphodiesterase VI inhibitor
0,131  0,091  Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor
0,047  0,007  Estrogen-related receptor beta antagonist
0,048  0,009  Tubulin agonist
0,063  0,024  Lysine-specific demethylase 1A inhibitor
0,122  0,084  Cocaine dependence treatment
0,103  0,066  Antiinfertility, female
0,080  0,043  Lipase inhibitor
0,082  0,045  Antidote, organophosphates
0,046  0,009  GABA transporter 3 inhibitor
0,067  0,032  Cyclin D1 inhibitor
0,052  0,016  Dihydrofolate reductase inhibitor
0,092  0,057  Triose-phosphate isomerase inhibitor
0,088  0,052  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,111  0,077  Antineoplastic antimetabolite
0,072  0,038  Exportin-1 inhibitor
0,059  0,025  Heparanase inhibitor
0,131  0,098  Pregnane X receptor agonist
0,058  0,025  Plasminogen activator inhibitor antagonist
0,048  0,017  Kainate receptor agonist
0,044  0,013  Sodium-dependent vitamin C transporter 2 inhibitor
0,051  0,020  Guanylate cyclase inhibitor
0,099  0,069  NAT2 substrate
0,105  0,076  Antiviral (Coronavirus)
0,105  0,076  Antiviral (SARS coronavirus)
0,059  0,030  Phosphodiesterase 4A inhibitor
0,041  0,012  ATP citrate lysase inhibitor
0,054  0,026  Potassium channel Kv1.3 blocker
0,158  0,131  Antiglaucomic
0,035  0,008  Estrogen-related receptor gamma antagonist
0,095  0,068  Nitric-oxide synthase inhibitor
0,062  0,035  Sphingosine kinase inhibitor
0,082  0,055  Adrenaline agonist
0,043  0,018  Leukotriene C4 antagonist
0,090  0,066  ABCA1 expression enhancer
0,060  0,036  Fatty acid synthase inhibitor
0,042  0,018  Phosphoglycerate kinase inhibitor
0,146  0,123  Toxic, respiratory center
0,119  0,097  Activin receptor-like kinase 2 inhibitor
0,097  0,075  HDL-cholesterol increasing
0,106  0,084  Interleukin 8 antagonist
0,041  0,020  Glutamate (mGluR8) agonist
0,043  0,023  Dihydropteroate synthase inhibitor
0,174  0,154  Huntington's disease treatment
0,069  0,050  Amidase inhibitor
0,035  0,016  Glutamate (mGluR3) agonist
0,028  0,010  Dopamine D1 agonist
0,118  0,099  Nav1.6 sodium channel blocker
0,032  0,014  Leukotriene D4 antagonist
0,166  0,148  Antidiabetic symptomatic
0,049  0,031  Glucose-6-phosphate isomerase inhibitor
0,047  0,029  Fructose-1,6-bisphosphatase inhibitor
0,032  0,015  Liver X receptor alpha antagonist
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,076  0,060  Platelet growth factor antagonist
0,041  0,025  Alpha 1d adrenoreceptor agonist
0,070  0,054  Peroxisome proliferator-activated receptor gamma antagonist
0,041  0,026  Cholesterol absorption inhibitor
0,028  0,013  Sodium/glucose cotransporter 1 inhibitor
0,104  0,088  Antiprotozoal (Babesia)
0,066  0,051  Phosphofructokinase-1 inhibitor
0,075  0,061  Antineoplastic antibiotic
0,142  0,127  Death-associated protein kinase 2 inhibitor
0,022  0,007  Antibiotic Trimethoprim-like
0,081  0,067  mTOR complex 2 inhibitor
0,095  0,081  Excitatory amino acid transporter EAAC1 inhibitor
0,070  0,056  Metalloproteinase-9 inhibitor
0,121  0,109  Insulin secretagoues
0,021  0,009  Antibiotic Anthracycline-like
0,020  0,008  Vesicular glutamate transport inhibitor
0,054  0,043  Adenine nucleotide translocase inhibitor
0,069  0,058  Alpha 2a adrenoreceptor antagonist
0,062  0,051  Dopamine agonist
0,027  0,016  Sodium/glucose cotransporter inhibitor
0,054  0,043  5 Hydroxytryptamine 7 agonist
0,092  0,082  Adenylate kinase inhibitor
0,023  0,014  Leukotriene B4 receptor 2 antagonist
0,129  0,119  Muscular dystrophy treatment
0,098  0,089  Nav1.5 sodium channel blocker
0,068  0,059  Antibiotic
0,082  0,073  Fibroblast growth factor 1 antagonist
0,043  0,034  Dihydroorotase inhibitor
0,033  0,025  Glutamate (mGluR4) agonist
0,015  0,007  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,055  0,047  Botulinum neurotoxin type A inhibitor
0,022  0,014  Vitamin D receptor antagonist
0,027  0,020  Hedgehog signaling activator
0,020  0,013  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,044  0,037  Peroxisome proliferator-activated receptor alpha agonist
0,048  0,042  Aconitate hydratase inhibitor
0,026  0,021  Leukotriene B4 receptor 1 antagonist
0,018  0,013  Estrogen-related receptor gamma agonist
0,137  0,132  Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor
0,059  0,055  Protease 3C (Human rhinovirus) inhibitor
0,122  0,118  Neuropeptide Y1 antagonist
0,034  0,031  Farnesoid X receptor agonist
0,053  0,049  Biliverdin reductase inhibitor
0,047  0,043  CD45 antagonist
0,018  0,015  Inosine monophosphate dehydrogenase 2 inhibitor
0,076  0,072  Alpha 2 adrenoreceptor antagonist
0,043  0,040  Beta adrenoreceptor agonist
0,025  0,022  Uridine phosphorylase inhibitor
0,062  0,059  NMDA 2 receptor antagonist
0,067  0,065  Nicotinic alpha4beta2 receptor antagonist
0,022  0,020  Fructose-1,6-bisphosphatase 1 inhibitor
0,024  0,022  Thyroid hormone agonist
0,079  0,078  Protein kinase C delta inhibitor
0,128  0,127  Antiviral (Hepatitis C)
0,006  0,004  Insulin like growth factor 3 antagonist
0,028  0,026  Liver X receptor antagonist
0,089  0,087  DNA intercalator
0,243  0,242  MAP kinase 1 inhibitor
0,163  0,162  5 Hydroxytryptamine 3E antagonist
0,020  0,020  Prostaglandin F2 alpha agonist

